Literature DB >> 1521388

Female-specific mood disorders.

M Steiner1.   

Abstract

Hormones are partial determinants of certain sexually dimorphic behaviors and interact with psychosocial, environmental, and other physiologic factors. The part played by sex hormones in the direct control of overt human behavior is, compared with that found in lower animals, slight and less readily definable. In humans, these hormones, although necessary for maintenance of libido and sexual behavior, seem to control the intensity of such behavior rather than its direction. In most women of reproductive age, the different phases of the menstrual cycle are not associated with major physical or psychologic discomfort. Some women actually report positive changes during the premenstrual period. Only 5-10% of women in this age group have changes in mood, sleep, eating habits, level of energy, and physical symptoms that appear to be linked temporally to the late-luteal phase of the cycle. It is plausible to assume that women with LLPDD are vulnerable to the menstrual cycle as a Zeitgeber. In these women, a cascade of events triggered originally along the HPG axis brings about the shift from an existing vulnerability to the actual manifestations of LLPDD and other forms of female-specific mood disorders. The degree of vulnerability becomes apparent at puberty when girls are exposed to increasing estrogenic influences. Particularly vulnerable times are the periods that mark shifts in the reproductive stages (menarche, the premenstruum, puerperium, and menopause), periods associated with major hormonal turmoil and psychosocial stresses. A conditioning-sensitization model has been described to explain the longitudinal course of affective disorders, and it also has been proposed for PMS. According to this model, even low levels of psychosocial stress are capable of triggering episodes of dysphoria in vulnerable previously sensitized subjects. LLPDD is associated strongly with a lifetime diagnosis of major depression, and the concurrent comorbidity in these women is also high. Future epidemiologic studies on depression should consider the effects of female-specific Zeitgeber on mood disorders in the populations studied.

Entities:  

Mesh:

Year:  1992        PMID: 1521388     DOI: 10.1097/00003081-199209000-00020

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  5 in total

Review 1.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

2.  Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.

Authors:  Susan Thys-Jacobs; Don McMahon; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

3.  Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study.

Authors:  Edilberto A Rocha Filho; José C Lima; João S Pinho Neto; Ulisses Montarroyos
Journal:  Reprod Health       Date:  2011-01-17       Impact factor: 3.223

Review 4.  Prenatal stress-immune programming of sex differences in comorbidity of depression and obesity/metabolic syndrome.

Authors:  Jill M Goldstein; Laura Holsen; Grace Huang; Bradley D Hammond; Tamarra James-Todd; Sara Cherkerzian; Taben M Hale; Robert J Handa
Journal:  Dialogues Clin Neurosci       Date:  2016-12       Impact factor: 5.986

5.  Fetal hormonal programming of sex differences in depression: linking women's mental health with sex differences in the brain across the lifespan.

Authors:  Jill M Goldstein; Laura Holsen; Robert Handa; Stuart Tobet
Journal:  Front Neurosci       Date:  2014-09-08       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.